| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 233,5 k € | +4.9% | 222,7 k € | +23.3% | 180,6 k € | -12.0% | 205,1 k € | -4.7% | 215,4 k € | +40.1% | 153,7 k € | -0.7% | 154,8 k € | +4.5% | 148,2 k € | +9.7% | 135,1 k € | +10.3% | 122,4 k € | -3.8% | 127,3 k € | +5.7% | 120,4 k € | +6.6% | 112,9 k € | -9.5% | 124,7 k € | +4.3% | 119,6 k € | +3.8% | 115,3 k € | +4.0% | 110,8 k € | +17.4% | 94,3 k € | |
| EBITDA | 231,2 k € | +4.9% | 220,5 k € | +23.3% | 178,9 k € | -12.1% | 203,5 k € | -4.8% | 213,7 k € | +41.9% | 150,5 k € | +3.3% | 145,8 k € | +6.1% | 137,4 k € | +13.8% | 120,7 k € | +12.3% | 107,5 k € | -1.9% | 109,6 k € | +3.0% | 106,5 k € | +9.6% | 97,1 k € | -12.1% | 110,4 k € | +4.2% | 106,0 k € | +3.4% | 102,5 k € | +6.3% | 96,5 k € | +19.1% | 81,0 k € | |
| Operating profit | 157,3 k € | +2.6% | 153,3 k € | +34.1% | 114,3 k € | -17.0% | 137,6 k € | -3.9% | 143,2 k € | +68.2% | 85,1 k € | +18.7% | 71,7 k € | -6.6% | 76,8 k € | +24.7% | 61,6 k € | +8.0% | 57,0 k € | -13.5% | 65,9 k € | +18.4% | 55,7 k € | +82.4% | 30,5 k € | -58.1% | 72,9 k € | +62.8% | 44,8 k € | +28.0% | 35,0 k € | +0.5% | 34,8 k € | -9.9% | 38,7 k € | |
| Profit/loss | 121,8 k € | +15.2% | 105,7 k € | +40.0% | 75,5 k € | -8.9% | 82,9 k € | -10.6% | 92,7 k € | +69.8% | 54,6 k € | +27.5% | 42,8 k € | -2.7% | 44,0 k € | +56.2% | 28,2 k € | -8.7% | 30,9 k € | -11.8% | 35,0 k € | +47.4% | 23,7 k € | +73.1% | 13,7 k € | -70.6% | 46,6 k € | +110.6% | 22,1 k € | +56.0% | 14,2 k € | -28.0% | 19,7 k € | -11.9% | 22,4 k € | |
| Equity | 958,2 k € | +14.6% | 836,4 k € | +14.5% | 730,7 k € | +11.5% | 655,2 k € | +14.5% | 572,3 k € | +19.3% | 479,6 k € | +12.8% | 425,0 k € | +11.2% | 382,2 k € | +13.0% | 338,2 k € | +9.1% | 310,0 k € | +11.1% | 279,2 k € | +14.3% | 244,2 k € | +10.8% | 220,4 k € | +6.6% | 206,7 k € | +20.1% | 172,1 k € | +14.8% | 150,0 k € | +10.4% | 135,8 k € | +17.0% | 116,1 k € | |
| Total assets | 982,9 k € | +14.6% | 857,7 k € | -0.1% | 858,9 k € | +10.3% | 778,3 k € | +11.0% | 701,1 k € | +0.8% | 695,5 k € | -10.8% | 779,9 k € | +8.1% | 721,7 k € | +8.5% | 665,1 k € | +10.3% | 602,9 k € | +5.5% | 571,3 k € | +8.5% | 526,5 k € | -6.8% | 565,0 k € | +36.9% | 412,8 k € | +0.8% | 409,4 k € | -6.4% | 437,5 k € | +0.0% | 437,3 k € | +104.9% | 213,4 k € | |
| Cash | 13,3 k € | -90.3% | 137,0 k € | -76.7% | 587,7 k € | +17.2% | 501,6 k € | +44.2% | 347,7 k € | +21.3% | 286,6 k € | -13.6% | 331,6 k € | +8.0% | 307,1 k € | +26.3% | 243,1 k € | +43.2% | 169,8 k € | +22.5% | 138,6 k € | +201.7% | 45,9 k € | +7.2% | 42,9 k € | +419.4% | 8,2 k € | -21.3% | 10,5 k € | -69.6% | 34,5 k € | +61.8% | 21,3 k € | +14.2% | 18,7 k € | |
| Debts | 24,7 k € | +22.2% | 20,2 k € | -83.9% | 125,5 k € | +4.4% | 120,2 k € | -2.7% | 123,5 k € | -41.2% | 210,2 k € | -35.9% | 327,9 k € | +7.8% | 304,0 k € | +9.2% | 278,4 k € | +13.1% | 246,1 k € | -4.2% | 257,0 k € | -1.7% | 261,5 k € | -21.3% | 332,2 k € | +69.9% | 195,5 k € | -13.0% | 224,6 k € | -18.7% | 276,2 k € | -6.7% | 296,1 k € | +219.9% | 92,6 k € | |
| Staff | — | — | — | — | — | — | — | — | — | 0,5 | 0,5 | 0,5 | 0,5 | 0,5 | 0,5 | 0,5 | 0,5 | 0,5 | ||||||||||||||||||
Private limited company · Wielsbeke · incorporated on 22/02/2001
Private limited company profitable and well capitalised. Cash position declining (-90.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. DEWITTE EN DR. SUNAERT is a Private limited company incorporated in 2001. Its main activity is: General medical practice activities. Its registered office is in Wielsbeke.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette